drugset / Trial / NCT01302743

Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM.

NCT01302743 ↗

Terminated 25 enrolled Mike O'Callaghan Military Hospital
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to assess whether Cinnamon bark or water-soluble cinnamon is an effective nutraceutical for the initial treatment of diabetes when compared to standard therapy of Metformin.

Timeline

Start
2010-11
Primary completion
2016-12
Completion
2016-12

Outcome

Outcome not reported

Stopped (Enrollment): “lack of recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 1000 mg Oral

Indications